BioCentury
ARTICLE | Clinical News

UshStat: Phase I/IIa ongoing

December 10, 2012 8:00 AM UTC

Oxford BioMedica said an independent DSMB recommended continuation to the second dose cohort in an open-label, dose-escalation, U.S. Phase I/IIa trial of UshStat after a review of data from 3 patients...